By Professor Glenda Halliday

Journal articles

Leak RK; Frosch MP; Beach TG; Halliday GM, 2019, 'Alpha-synuclein: prion or prion-like?', Acta Neuropathologica, 138, pp. 509 - 514, http://dx.doi.org/10.1007/s00401-019-02057-1

Shehadeh J; Double KL; Murphy KE; Bobrovskaya L; Reyes S; Dunkley PR; Halliday GM; Dickson PW, 2019, 'Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease', Neurobiology of Disease, 130, http://dx.doi.org/10.1016/j.nbd.2019.104524

Gao J; Perera G; Bhadbhade M; Halliday GM; Dzamko N, 2019, 'Autophagy activation promotes clearance of α-synuclein inclusions in fibril-seeded human neural cells', Journal of Biological Chemistry, 294, pp. 14241 - 14256, http://dx.doi.org/10.1074/jbc.RA119.008733

Ke YD; Chan G; Stefanoska K; Au C; Bi M; Müller J; Przybyla M; Feiten A; Prikas E; Halliday GM; Piguet O; Kiernan MC; Kassiou M; Hodges JR; Loy CT; Mattick JS; Ittner A; Kril JJ; Sutherland GT; Ittner LM, 2019, 'CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation', Journal of Biological Chemistry, 294, pp. 14149 - 14162, http://dx.doi.org/10.1074/jbc.RA118.005263

Lee JS; Kanai K; Suzuki M; Kim WS; Yoo HS; Fu YH; Kim DK; Jung BC; Choi M; Oh KW; Li Y; Nakatani M; Nakazato T; Sekimoto S; Funayama M; Yoshino H; Kubo SI; Nishioka K; Sakai R; Ueyama M; Mochizuki H; Lee HJ; Sardi SP; Halliday GM; Nagai Y; Lee PH; Hattori N; Lee SJ, 2019, 'Arylsulfatase A, a genetic modifier of Parkinson’s disease, is an α-synuclein chaperone', Brain, 142, pp. 2845 - 2859, http://dx.doi.org/10.1093/brain/awz205

Matar E; Phillips JR; Martens KAE; Halliday GM; Lewis SJG, 2019, 'Impaired Color Discrimination—A Specific Marker of Hallucinations in Lewy Body Disorders', Journal of Geriatric Psychiatry and Neurology, 32, pp. 257 - 264, http://dx.doi.org/10.1177/0891988719845501

Shepherd CE; McGeachie AB; Affleck AJ; Halliday GM, 2019, 'Letter to the editor', Journal of Neuropathology and Experimental Neurology, 78, pp. 975, http://dx.doi.org/10.1093/jnen/nlz069

Bright F; Werry EL; Dobson-Stone C; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kassiou M; Kril JJ, 2019, 'Neuroinflammation in frontotemporal dementia', Nature Reviews Neurology, 15, pp. 540 - 555, http://dx.doi.org/10.1038/s41582-019-0231-z

Nelson PT; Dickson DW; Trojanowski JQ; Jack CR; Boyle PA; Arfanakis K; Rademakers R; Alafuzoff I; Attems J; Brayne C; Coyle-Gilchrist ITS; Fardo DW; Flanagan ME; Halliday G; Hunter S; Jicha GA; Katsumata Y; Kawas CH; Dirk Keene C; Kovacs GG; Kukull WA; Levey AI; Makkinejad N; Montine TJ; Murray ME; Nag S; Seeley WW; Sperling RA; White CL; Schneider JA, 2019, 'Reply: LATE to the PART-y', Brain, 142, pp. 1 - 3, http://dx.doi.org/10.1093/brain/awz226

Ehgoetz Martens KA; Matar E; Hall JM; Phillips J; Szeto JYY; Gouelle A; Grunstein RR; Halliday GM; Lewis SJG, 2019, 'Subtle gait and balance impairments occur in idiopathic rapid eye movement sleep behavior disorder', Movement Disorders, 34, pp. 1374 - 1380, http://dx.doi.org/10.1002/mds.27780

Zhang Q; Vallerga CL; Walker RM; Lin T; Henders AK; Montgomery GW; He J; Fan D; Fowdar J; Kennedy M; Pitcher T; Pearson J; Halliday G; Kwok JB; Hickie I; Lewis S; Anderson T; Silburn PA; Mellick GD; Harris SE; Redmond P; Murray AD; Porteous DJ; Haley CS; Evans KL; McIntosh AM; Yang J; Gratten J; Marioni RE; Wray NR; Deary IJ; McRae AF; Visscher PM, 2019, 'Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing', Genome Medicine, 11, http://dx.doi.org/10.1186/s13073-019-0667-1

Buckland ME; Sy J; Szentmariay I; Kullen A; Lee M; Harding A; Halliday G; Suter CM, 2019, 'Erratum: Correction to: Chronic traumatic encephalopathy in two former Australian National Rugby League players (Acta neuropathologica communications (2019) 7 1 (97))', Acta Neuropathologica Communications, 7, pp. 122, http://dx.doi.org/10.1186/s40478-019-0772-9

Katzeff JS; Phan K; Purushothuman S; Halliday GM; Kim WS, 2019, 'Cross-examining candidate genes implicated in multiple system atrophy', Acta Neuropathologica Communications, 7, pp. 117, http://dx.doi.org/10.1186/s40478-019-0769-4

Crook A; McEwen A; Fifita JA; Zhang K; Kwok JB; Halliday G; Blair IP; Rowe DB, 2019, 'The C9orf72 hexanucleotide repeat expansion presents a challenge for testing laboratories and genetic counseling', Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20, pp. 310 - 316, http://dx.doi.org/10.1080/21678421.2019.1588904

Stankovic I; Quinn N; Vignatelli L; Antonini A; Berg D; Coon E; Cortelli P; Fanciulli A; Ferreira JJ; Freeman R; Halliday G; Höglinger GU; Iodice V; Kaufmann H; Klockgether T; Kostic V; Krismer F; Lang A; Levin J; Low P; Mathias C; Meissner WG; Kaufmann LN; Palma JA; Panicker JN; Pellecchia MT; Sakakibara R; Schmahmann J; Scholz SW; Singer W; Stamelou M; Tolosa E; Tsuji S; Seppi K; Poewe W; Wenning GK, 2019, 'A critique of the second consensus criteria for multiple system atrophy', Movement Disorders, 34, pp. 975 - 984, http://dx.doi.org/10.1002/mds.27701

Nelson PT; Dickson DW; Trojanowski JQ; Jack CR; Boyle PA; Arfanakis K; Rademakers R; Alafuzoff I; Attems J; Brayne C; Coyle-Gilchrist ITS; Chui HC; Fardo DW; Flanagan ME; Halliday G; Hokkanen SRK; Hunter S; Jicha GA; Katsumata Y; Kawas CH; Keene CD; Kovacs GG; Kukull WA; Levey AI; Makkinejad N; Montine TJ; Murayama S; Murray ME; Nag S; Rissman RA; Seeley WW; Sperling RA; White CL; Yu L; Schneider JA, 2019, 'Erratum: Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. (Brain (2019) 142, (1503–1527) DOI: 10.1093/brain/awz099)', Brain, 142, http://dx.doi.org/10.1093/brain/awz163

Guerreiro R; Escott-Price V; Hernandez DG; Kun-Rodrigues C; Ross OA; Orme T; Neto JL; Carmona S; Dehghani N; Eicher JD; Shepherd C; Parkkinen L; Darwent L; Heckman MG; Scholz SW; Troncoso JC; Pletnikova O; Dawson T; Rosenthal L; Ansorge O; Clarimon J; Lleo A; Morenas-Rodriguez E; Clark L; Honig LS; Marder K; Lemstra A; Rogaeva E; St. George-Hyslop P; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Serrano GE; Beach TG; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Diez-Fairen M; Aguilar M; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Graff-Radford N; Cairns NJ; Morris JC; Pickering-Brown S; Mann D; Halliday GM; Hardy J; Trojanowski JQ; Dickson DW; Singleton A; Stone DJ; Bras J, 2019, 'Heritability and genetic variance of dementia with Lewy bodies', Neurobiology of Disease, 127, pp. 492 - 501, http://dx.doi.org/10.1016/j.nbd.2019.04.004

Stevens CH; Guthrie NJ; Van Roijen M; Halliday GM; Ooi L, 2019, 'Increased tau phosphorylation in motor neurons from clinically pure sporadic amyotrophic lateral sclerosis patients', Journal of Neuropathology and Experimental Neurology, 78, pp. 605 - 614, http://dx.doi.org/10.1093/jnen/nlz041

Werry EL; Bright FM; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kril JJ; Kassiou M, 2019, 'Recent developments in TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders', International Journal of Molecular Sciences, 20, http://dx.doi.org/10.3390/ijms20133161

Buckland ME; Sy J; Szentmariay I; Kullen A; Lee M; Harding A; Halliday G; Suter CM, 2019, 'Chronic traumatic encephalopathy in two former Australian National Rugby League players', Acta Neuropathologica Communications, 7, pp. 97, http://dx.doi.org/10.1186/s40478-019-0751-1

Pottier C; Ren Y; Perkerson RB; Baker M; Jenkins GD; van Blitterswijk M; DeJesus-Hernandez M; van Rooij JGJ; Murray ME; Christopher E; McDonnell SK; Fogarty Z; Batzler A; Tian S; Vicente CT; Matchett B; Karydas AM; Hsiung GYR; Seelaar H; Mol MO; Finger EC; Graff C; Öijerstedt L; Neumann M; Heutink P; Synofzik M; Wilke C; Prudlo J; Rizzu P; Simon-Sanchez J; Edbauer D; Roeber S; Diehl-Schmid J; Evers BM; King A; Mesulam MM; Weintraub S; Geula C; Bieniek KF; Petrucelli L; Ahern GL; Reiman EM; Woodruff BK; Caselli RJ; Huey ED; Farlow MR; Grafman J; Mead S; Grinberg LT; Spina S; Grossman M; Irwin DJ; Lee EB; Suh ER; Snowden J; Mann D; Ertekin-Taner N; Uitti RJ; Wszolek ZK; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Hodges JR; Piguet O; Geier EG; Yokoyama JS; Rissman RA; Rogaeva E; Keith J; Zinman L; Tartaglia MC; Cairns NJ; Cruchaga C; Ghetti B; Kofler J; Lopez OL; Beach TG; Arzberger T; Herms J; Honig LS; Vonsattel JP; Halliday GM; Kwok JB; White CL; Gearing M; Glass J; Rollinson S; Pickering-Brown S; Rohrer JD; Trojanowski JQ; Van Deerlin V; Bigio EH; Troakes C; Al-Sarraj S; Asmann Y; Miller BL; Graff-Radford NR; Boeve BF; Seeley WW, 2019, 'Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD', Acta Neuropathologica, 137, pp. 879 - 899, http://dx.doi.org/10.1007/s00401-019-01962-9

Nelson PT; Dickson DW; Trojanowski JQ; Jack CR; Boyle PA; Arfanakis K; Rademakers R; Alafuzoff I; Attems J; Brayne C; Coyle-Gilchrist ITS; Chui HC; Fardo DW; Flanagan ME; Halliday G; Hokkanen SRK; Hunter S; Jicha GA; Katsumata Y; Kawas CH; Keene CD; Kovacs GG; Kukull WA; Levey AI; Makkinejad N; Montine TJ; Murayama S; Murray ME; Nag S; Rissman RA; Seeley WW; Sperling RA; White CL; Yu L; Schneider JA, 2019, 'Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus working group report', Brain, 142, pp. 1503 - 1527, http://dx.doi.org/10.1093/brain/awz099

Baldo B; Gabery S; Soylu-Kucharz R; Cheong RY; Henningsen JB; Englund E; McLean C; Kirik D; Halliday G; Petersén , 2019, 'SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease', Neuropathology and Applied Neurobiology, 45, pp. 361 - 379, http://dx.doi.org/10.1111/nan.12514

Warren Olanow C; Savolainen M; Chu Y; Halliday GM; Kordower JH, 2019, 'Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson's disease', Brain, 142, pp. 1690 - 1700, http://dx.doi.org/10.1093/brain/awz104

Forrest SL; Crockford DR; Sizemova A; Mccann H; Shepherd CE; Mcgeachie AB; Affleck AJ; Carew-Jones F; Bartley L; Kwok JB; Kim WS; Jary E; Tan RH; Mcginley CV; Piguet O; Hodges JR; Kril JJ; Halliday GM, 2019, 'Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration', Neurology, 92, pp. e2472 - e2482, http://dx.doi.org/10.1212/WNL.0000000000007530

Agarwal S; Ahmed RM; D'Mello M; Foxe D; Kaizik C; Kiernan MC; Halliday GM; Piguet O; Hodges JR, 2019, 'Predictors of survival and progression in behavioural variant frontotemporal dementia', European Journal of Neurology, 26, pp. 774 - 779, http://dx.doi.org/10.1111/ene.13887

Shepherd CE; Alvendia H; Halliday GM, 2019, 'Brain Banking for Research into Neurodegenerative Disorders and Ageing', Neuroscience Bulletin, 35, pp. 283 - 288, http://dx.doi.org/10.1007/s12264-018-0326-3

Shine JM; Bell PT; Matar E; Poldrack RA; Lewis SJG; Halliday GM; O'Callaghan C, 2019, 'Dopamine depletion alters macroscopic network dynamics in Parkinson's disease', Brain, 142, pp. 1024 - 1034, http://dx.doi.org/10.1093/brain/awz034

Tan RH; Guennewig B; Dobson-Stone C; Kwok JBJ; Kril JJ; Kiernan MC; Hodges JR; Piguet O; Halliday GM, 2019, 'The underacknowledged PPA-ALS: A unique clinicopathologic subtype with strong heritability', Neurology, 92, pp. E1354 - E1366, http://dx.doi.org/10.1212/WNL.0000000000007146

Woerman AL; Oehler A; Kazmi SA; Lee J; Halliday GM; Middleton LT; Gentleman SM; Mordes DA; Spina S; Grinberg LT; Olson SH; Prusiner SB, 2019, 'Multiple system atrophy prions retain strain specificity after serial propagation in two different Tg(SNCA*A53T) mouse lines', Acta Neuropathologica, 137, pp. 437 - 454, http://dx.doi.org/10.1007/s00401-019-01959-4

Kun-Rodrigues C; Orme T; Carmona S; Hernandez DG; Ross OA; Eicher JD; Shepherd C; Parkkinen L; Darwent L; Heckman MG; Scholz SW; Troncoso JC; Pletnikova O; Dawson T; Rosenthal L; Ansorge O; Clarimon J; Lleo A; Morenas-Rodriguez E; Clark L; Honig LS; Marder K; Lemstra A; Rogaeva E; St. George-Hyslop P; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Serrano GE; Beach TG; Lesage S; Galasko D; Masliah E; Santana I; Pastor P; Diez-Fairen M; Aguilar M; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Escott-Price V; Graff-Radford N; Cairns NJ; Morris JC; Pickering-Brown S; Mann D; Halliday GM; Hardy J; Trojanowski JQ; Dickson DW; Singleton A; Stone DJ; Guerreiro R; Bras J, 2019, 'A comprehensive screening of copy number variability in dementia with Lewy bodies', Neurobiology of Aging, 75, pp. 223 - 223.e10, http://dx.doi.org/10.1016/j.neurobiolaging.2018.10.019

Ahmed RM; Phan K; Highton-Williamson E; Strikwerda-Brown C; Caga J; Ramsey E; Zoing M; Devenney E; Kim WS; Hodges JR; Piguet O; Halliday GM; Kiernan MC, 2019, 'Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia', Annals of Clinical and Translational Neurology, 6, pp. 486 - 495, http://dx.doi.org/10.1002/acn3.721

Breen DP; Halliday GM; Lang AE, 2019, 'Gut–brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?', Movement Disorders, 34, pp. 307 - 316, http://dx.doi.org/10.1002/mds.27556

Atashrazm F; Hammond D; Perera G; Bolliger MF; Matar E; Halliday GM; Schüle B; Lewis SJG; Nichols RJ; Dzamko N, 2019, 'LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients', Movement Disorders, 34, pp. 406 - 415, http://dx.doi.org/10.1002/mds.27601

Kennett J; Carter A; Bourne JA; Hall W; Levy N; Mattingley JB; Lawrence AJ; Forlini C; Malcolm L; Vincent N; Richards LJ; Egan GF; Breakspear M; Cornish K; Halliday G; Poole-Warren L; Sriram S; Soulis T; Fitzgibbon B; Kiral-Kornek I; Badcock DR; Balleine B; Bekkers JM; Berk M; Bradley A; Brichta A; Carter O; Castles A; Clements J; Cornish J; de Zubicaray G; Enticott PG; Fornito A; Griffiths L; Gullifer J; Hannan AJ; Harrer S; Harvey A; Hickie IB; Jazwinska L; Kiernan M; Kilpatrick T; Leventer R; Licinio J; Lovell N; Mackellar G; Medland SE; Michie PT; Nithianantharajah J; Parker J; Payne JM; Rossell S; Sah P; Sarnyai Z; Schofield PR; Shum DHK; Silk T; Slee M; Stuart GJ; Tapson J; van Schaik A; Vissel B; Waters A; Apthorp D; Cohen-Woods S; Conn SJ; Korgaonkar M; Mason A; Azghadi MR; Shimoni O; Smith A; Thompson MB, 2019, 'A Neuroethics Framework for the Australian Brain Initiative', Neuron, 101, pp. 365 - 369, http://dx.doi.org/10.1016/j.neuron.2019.01.004

Newman M; Moussavi Nik H; Sutherland G; Kim W; Halliday G; Jayadev S; Smith C; Kittipassorn T; Peet D; Lardelli M, 2019, 'Accelerated loss of hypoxia response and biased allele expression in zebrafish with Alzheimer's disease-like mutations', , http://dx.doi.org/10.1101/526277

Bhatia S; Kim WS; Shepherd CE; Halliday GM, 2019, 'Apolipoprotein D Upregulation in Alzheimer’s Disease but Not Frontotemporal Dementia', Journal of Molecular Neuroscience, 67, pp. 125 - 132, http://dx.doi.org/10.1007/s12031-018-1217-9

Aoyagi A; Condello C; Stöhr J; Yue W; Rivera BM; Lee JC; Woerman AL; Halliday G; Van Duinen S; Ingelsson M; Lannfelt L; Graff C; Bird TD; Keene CD; Seeley WW; DeGrado WF; Prusiner SB, 2019, 'Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain', Science Translational Medicine, 11, http://dx.doi.org/10.1126/scitranslmed.aat8462

Swarup V; Hinz FI; Rexach JE; Noguchi KI; Toyoshiba H; Oda A; Hirai K; Sarkar A; Seyfried NT; Cheng C; Haggarty SJ; Ferrari R; Rohrer JD; Ramasamy A; Hardy J; Hernandez DG; Nalls MA; Singleton AB; Kwok JBJ; Dobson-Stone C; Brooks WS; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cairns NJ; Cruchaga C; Binetti G; Ghidoni R; Benussi L; Forloni G; Albani D; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Waldö ML; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Jaros E; Pietrini P; Huey ED; Wassermann EM; Tierney MC; Baborie A; Pastor P; Ortega-Cubero S; Razquin C; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; George-Hyslop PS; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ; Pickering-Brown S; Momeni P; van der Zee J; Cruts M; Van Broeckhoven C; Cappa SF; Leber I; Brice A; Hannequin D; Golfier V, 2019, 'Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia', Nature Medicine, 25, pp. 152 - 164, http://dx.doi.org/10.1038/s41591-018-0223-3

Götz J; Halliday G; Nisbet RM, 2019, 'Molecular Pathogenesis of the Tauopathies', Annual Review of Pathology: Mechanisms of Disease, 14, pp. 239 - 261, http://dx.doi.org/10.1146/annurev-pathmechdis-012418-012936

Hardwick SA; Bassett SD; Kaczorowski D; Blackburn J; Barton K; Bartonicek N; Carswell SL; Tilgner HU; Loy C; Halliday G; Mercer TR; Smith MA; Mattick JS, 2019, 'Targeted, high-resolution RNA sequencing of non-coding genomic regions associated with neuropsychiatric functions', Frontiers in Genetics, 10, pp. 309, http://dx.doi.org/10.3389/fgene.2019.00309

Tan RH; Yang Y; McCann H; Shepherd C; Halliday GM; Whitwell J, 2019, 'Von economo neurons in behavioral variant frontotemporal dementia with underlying Alzheimer's disease', Journal of Alzheimer S Disease, 69, pp. 963 - 967, http://dx.doi.org/10.3233/JAD-180900

Pires G; Prelli F; Halliday GM; McElligott S; Drusinsky S; Wisniewski T; Drummond E, 2019, 'O4‐01‐06: SECERNIN‐1 IS A NOVEL PHOSPHORYLATED TAU BINDING PROTEIN THAT ACCUMULATES IN ALZHEIMER'S DISEASE AND NOT IN OTHER TAUOPATHIES', Alzheimer's & Dementia, 15, http://dx.doi.org/10.1016/j.jalz.2019.06.4745

Heinzel S; Berg D; Gasser T; Chen H; Yao C; Postuma RB; Adler CH; Bloem B; Chan P; Deuschl G; Dubois B; Goetz CG; Halliday GM; Hardy J; Lang AE; Litvan I; Marek K; Obeso J; Oertel W; Olanow CW; Poewe W; Stern M, 2019, 'Update of the MDS research criteria for prodromal Parkinson's disease', MOVEMENT DISORDERS, 34, pp. 1464 - 1470, http://dx.doi.org/10.1002/mds.27802

Farrell AW; Halliday GM; Lyons JG, 2018, 'Brahma deficiency in keratinocytes promotes UV carcinogenesis by accelerating the escape from cell cycle arrest and the formation of DNA photolesions', Journal of Dermatological Science, 92, pp. 254 - 263, http://dx.doi.org/10.1016/j.jdermsci.2018.11.006

Bonham LW; Karch CM; Fan CC; Tan C; Geier EG; Wang Y; Wen N; Broce IJ; Li Y; Barkovich MJ; Ferrari R; Hardy J; Momeni P; Höglinger G; Müller U; Hess CP; Sugrue LP; Dillon WP; Schellenberg GD; Miller BL; Andreassen OA; Dale AM; Barkovich AJ; Yokoyama JS; Desikan RS; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Albani D; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Waldö ML; Nilsson K; Nilsson C; MacKenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; George-Hyslop PS; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ, 2018, 'CXCR4 involvement in neurodegenerative diseases', Translational Psychiatry, 8, pp. 73, http://dx.doi.org/10.1038/s41398-017-0049-7

Schwartz RS; Halliday GM; Soh D; Cordato DJ; Kril JJ, 2018, 'Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson's disease', Journal of Clinical Neuroscience, 58, pp. 70 - 74, http://dx.doi.org/10.1016/j.jocn.2018.10.029

Guerreiro R; Orme T; Neto JL; Bras J; Hardy J; Kun-Rodrigues C; Darwent L; Carmona S; Ansorge O; Parkkinen L; Morgan K; Brown K; Braae A; Barber I; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Revesz T; Lees A; Zetterberg H; Escott-Price V; Pickering-Brown S; Mann D; Singleton A; Hernandez D; Ross O; Dickson D; Graff-Radford N; Ferman T; Petersen R; Boeve B; Heckman M; Trojanowski JQ; Van Deerlin V; Cairns N; Morris J; Stone DA; Eicher J; Clark L; Honig L; Marder K; Serrano G; Beach T; Galasko D; Masliah E; Rogaeva E; St. George-Hyslop P; Clarimon J; Lleo A; Morenas-Rodriguez E; Pastor P; Diez-Fairen M; Aquilar M; Shepherd C; Halliday G; Tienari P; Myllykangas L; Oinas M; Santana I; Lesage S; Londos E; Lemstra A, 2018, 'LRP10 in α-synucleinopathies', Lancet Neurology, 17, pp. 1032 - 1033, http://dx.doi.org/10.1016/S1474-4422(18)30399-5

Zhao Y; Keshiya S; Atashrazm F; Gao J; Ittner LM; Alessi DR; Halliday GM; Fu Y; Dzamko N, 2018, 'Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice', Neurobiology of Disease, 120, pp. 76 - 87, http://dx.doi.org/10.1016/j.nbd.2018.09.003

Atashrazm F; Hammond D; Perera G; Dobson-Stone C; Mueller N; Pickford R; Kim WS; Kwok JB; Lewis SJG; Halliday GM; Dzamko N, 2018, 'Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease', Scientific Reports, 8, http://dx.doi.org/10.1038/s41598-018-33921-x

Back to profile page